292 related articles for article (PubMed ID: 12600822)
1. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade.
Tuder RM; Zhen L; Cho CY; Taraseviciene-Stewart L; Kasahara Y; Salvemini D; Voelkel NF; Flores SC
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):88-97. PubMed ID: 12600822
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema.
Kasahara Y; Tuder RM; Taraseviciene-Stewart L; Le Cras TD; Abman S; Hirth PK; Waltenberger J; Voelkel NF
J Clin Invest; 2000 Dec; 106(11):1311-9. PubMed ID: 11104784
[TBL] [Abstract][Full Text] [Related]
3. Emphysema: an autoimmune vascular disease?
Voelkel N; Taraseviciene-Stewart L
Proc Am Thorac Soc; 2005; 2(1):23-5. PubMed ID: 16113465
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine treatment protects against VEGF-receptor blockade-related emphysema.
Demura Y; Taraseviciene-Stewart L; Scerbavicius R; Tuder RM; Voelkel NF
COPD; 2004 Apr; 1(1):25-32. PubMed ID: 16997736
[TBL] [Abstract][Full Text] [Related]
5. Sulfated dehydropolymer of caffeic acid: In vitro anti-lung cell death activity and in vivo intervention in emphysema induced by VEGF receptor blockade.
Truong TM; Li H; Dhapare S; Desai UR; Voelkel NF; Sakagami M
Pulm Pharmacol Ther; 2017 Aug; 45():181-190. PubMed ID: 28648907
[TBL] [Abstract][Full Text] [Related]
6. A novel antiapoptotic role for alpha1-antitrypsin in the prevention of pulmonary emphysema.
Petrache I; Fijalkowska I; Zhen L; Medler TR; Brown E; Cruz P; Choe KH; Taraseviciene-Stewart L; Scerbavicius R; Shapiro L; Zhang B; Song S; Hicklin D; Voelkel NF; Flotte T; Tuder RM
Am J Respir Crit Care Med; 2006 Jun; 173(11):1222-8. PubMed ID: 16514110
[TBL] [Abstract][Full Text] [Related]
7. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.
Cai S; Chen P; Zhang C; Chen JB; Wu J
Respirology; 2009 Apr; 14(3):354-9. PubMed ID: 19341424
[TBL] [Abstract][Full Text] [Related]
8. The effects of antiangiogenic compound SU5416 in a rat model of pulmonary arterial hypertension.
Sakao S; Tatsumi K
Respiration; 2011; 81(3):253-61. PubMed ID: 21116108
[TBL] [Abstract][Full Text] [Related]
9. Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition.
Tang JR; Seedorf G; Balasubramaniam V; Maxey A; Markham N; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1271-80. PubMed ID: 17827251
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
Haspel HC; Scicli GM; McMahon G; Scicli AG
Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
[TBL] [Abstract][Full Text] [Related]
11. Superoxide dismutase protects against apoptosis and alveolar enlargement induced by ceramide.
Petrache I; Medler TR; Richter AT; Kamocki K; Chukwueke U; Zhen L; Gu Y; Adamowicz J; Schweitzer KS; Hubbard WC; Berdyshev EV; Lungarella G; Tuder RM
Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L44-53. PubMed ID: 18441093
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor receptor blockade by SU5416 combined with pulsatile shear stress causes apoptosis and subsequent proliferation of apoptosis-resistant endothelial cells.
Sakao S; Taraseviciene-Stewart L; Lee JD; Wood K; Cool CD; Voelkel NF
Chest; 2005 Dec; 128(6 Suppl):610S-611S. PubMed ID: 16373861
[No Abstract] [Full Text] [Related]
13. Vascular endothelial growth factor-mediated angiogenesis inhibition and postoperative wound healing in rats.
Roman CD; Choy H; Nanney L; Riordan C; Parman K; Johnson D; Beauchamp RD
J Surg Res; 2002 Jun; 105(1):43-7. PubMed ID: 12069500
[TBL] [Abstract][Full Text] [Related]
14. [Role of alveolar cell apoptosis in COPD].
Aoshiba K
Nihon Rinsho; 2007 Apr; 65(4):629-32. PubMed ID: 17419379
[TBL] [Abstract][Full Text] [Related]
15. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
16. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells.
Sakao S; Taraseviciene-Stewart L; Lee JD; Wood K; Cool CD; Voelkel NF
FASEB J; 2005 Jul; 19(9):1178-80. PubMed ID: 15897232
[TBL] [Abstract][Full Text] [Related]
17. [Expression of pulmonary vascular endothelial growth factor and vascular endothelial growth factor receptor in emphysema].
Wang YH; Bai CX; Mao L; Zhang M
Zhonghua Nei Ke Za Zhi; 2005 Apr; 44(4):276-9. PubMed ID: 15924642
[TBL] [Abstract][Full Text] [Related]
18. Salvianolic acid B as an anti-emphysema agent I: In vitro stimulation of lung cell proliferation and migration, and protection against lung cell death, and in vivo lung STAT3 activation and VEGF elevation.
Dhapare S; Sakagami M
Pulm Pharmacol Ther; 2018 Dec; 53():107-115. PubMed ID: 30291890
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
Taraseviciene-Stewart L; Kasahara Y; Alger L; Hirth P; Mc Mahon G; Waltenberger J; Voelkel NF; Tuder RM
FASEB J; 2001 Feb; 15(2):427-38. PubMed ID: 11156958
[TBL] [Abstract][Full Text] [Related]
20. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
